144 related articles for article (PubMed ID: 20923686)
1. Serologic cross-reactivity among humans and birds infected with highly pathogenic avian influenza A subtype H5N1 viruses in China.
Li Z; Ma C; Liu Z; He W
Immunol Lett; 2011 Mar; 135(1-2):59-63. PubMed ID: 20923686
[TBL] [Abstract][Full Text] [Related]
2. [Monoclonal antibodies to highly pathogenic avian influenza A(H5N1) strain isolated in the Russian Federation: development and properties].
Kushch AA; Klimova RR; Masalova OV; Fedorova NE; Botikov AG; Fediakina IT; Burtseva EI; Isaeva EI; Deriabin PG; L'vov DK
Vopr Virusol; 2008; 53(5):9-14. PubMed ID: 19069786
[TBL] [Abstract][Full Text] [Related]
3. A triclade DNA vaccine designed on the basis of a comprehensive serologic study elicits neutralizing antibody responses against all clades and subclades of highly pathogenic avian influenza H5N1 viruses.
Zhou F; Wang G; Buchy P; Cai Z; Chen H; Chen Z; Cheng G; Wan XF; Deubel V; Zhou P
J Virol; 2012 Jun; 86(12):6970-8. PubMed ID: 22496212
[TBL] [Abstract][Full Text] [Related]
4. A novel pathogenic mechanism of highly pathogenic avian influenza H5N1 viruses involves hemagglutinin mediated resistance to serum innate inhibitors.
Panaampon J; Ngaosuwankul N; Suptawiwat O; Noisumdaeng P; Sangsiriwut K; Siridechadilok B; Lerdsamran H; Auewarakul P; Pooruk P; Puthavathana P
PLoS One; 2012; 7(5):e36318. PubMed ID: 22563489
[TBL] [Abstract][Full Text] [Related]
5. A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies.
Temperton NJ; Hoschler K; Major D; Nicolson C; Manvell R; Hien VM; Ha do Q; de Jong M; Zambon M; Takeuchi Y; Weiss RA
Influenza Other Respir Viruses; 2007 May; 1(3):105-12. PubMed ID: 19453415
[TBL] [Abstract][Full Text] [Related]
6. Cross-Protection by Inactivated H5 Prepandemic Vaccine Seed Strains against Diverse Goose/Guangdong Lineage H5N1 Highly Pathogenic Avian Influenza Viruses.
Criado MF; Sá E Silva M; Lee DH; Salge CAL; Spackman E; Donis R; Wan XF; Swayne DE
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999029
[TBL] [Abstract][Full Text] [Related]
7. Genetic and antigenic characterization of influenza A/H5N1 viruses isolated from patients in Indonesia, 2008-2015.
Pawestri HA; Nugraha AA; Han AX; Pratiwi E; Parker E; Richard M; van der Vliet S; Fouchier RAM; Muljono DH; de Jong MD; Setiawaty V; Eggink D
Virus Genes; 2020 Aug; 56(4):417-429. PubMed ID: 32483655
[TBL] [Abstract][Full Text] [Related]
8. Characterizing wild bird contact and seropositivity to highly pathogenic avian influenza A (H5N1) virus in Alaskan residents.
Reed C; Bruden D; Byrd KK; Veguilla V; Bruce M; Hurlburt D; Wang D; Holiday C; Hancock K; Ortiz JR; Klejka J; Katz JM; Uyeki TM
Influenza Other Respir Viruses; 2014 Sep; 8(5):516-23. PubMed ID: 24828535
[TBL] [Abstract][Full Text] [Related]
9. Development of broadly reactive H5N1 vaccine against different Egyptian H5N1 viruses.
Ibrahim M; Sultan HA; Razik AG; Kang KI; Arafa AS; Shehata AA; Saif YM; Lee CW
Vaccine; 2015 May; 33(23):2670-7. PubMed ID: 25910922
[TBL] [Abstract][Full Text] [Related]
10. Prime-Boost Vaccination With a Novel Hemagglutinin Protein Produced in Bacteria Induces Neutralizing Antibody Responses Against H5-Subtype Influenza Viruses in Commercial Chickens.
Sączyńska V; Romanik-Chruścielewska A; Florys K; Cecuda-Adamczewska V; Łukasiewicz N; Sokołowska I; Kęsik-Brodacka M; Płucienniczak G
Front Immunol; 2019; 10():2006. PubMed ID: 31552018
[TBL] [Abstract][Full Text] [Related]
11. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
12. Development of monoclonal antibodies to highly pathogenic avian influenza H5N1 virus and their application to diagnostics, prophylaxis, and therapy.
Masalova OV; Klimova RR; Chichev EV; Fediakina IT; Loginova SY; Borisevich SV; Bondarev VP; Deryabin PG; Lvov DK; Kushch AA
Acta Virol; 2011; 55(1):3-14. PubMed ID: 21434700
[TBL] [Abstract][Full Text] [Related]
13. Antigenic characterization of highly pathogenic avian influenza A(H5N1) viruses with chicken and ferret antisera reveals clade-dependent variation in hemagglutination inhibition profiles.
Thi Nguyen D; Shepard SS; Burke DF; Jones J; Thor S; Nguyen LV; Nguyen TD; Balish A; Hoang DN; To TL; Iqbal M; Wentworth DE; Spackman E; van Doorn HR; Davis CT; Bryant JE
Emerg Microbes Infect; 2018 May; 7(1):100. PubMed ID: 29855467
[TBL] [Abstract][Full Text] [Related]
14. A novel peptide ELISA for universal detection of antibodies to human H5N1 influenza viruses.
Velumani S; Ho HT; He F; Musthaq S; Prabakaran M; Kwang J
PLoS One; 2011; 6(6):e20737. PubMed ID: 21695200
[TBL] [Abstract][Full Text] [Related]
15. Genetic versus antigenic differences among highly pathogenic H5N1 avian influenza A viruses: Consequences for vaccine strain selection.
Peeters B; Reemers S; Dortmans J; de Vries E; de Jong M; van de Zande S; Rottier PJM; de Haan CAM
Virology; 2017 Mar; 503():83-93. PubMed ID: 28135661
[TBL] [Abstract][Full Text] [Related]
16. Epitope mapping of neutralizing monoclonal antibody in avian influenza A H5N1 virus hemagglutinin.
Ohkura T; Kikuchi Y; Kono N; Itamura S; Komase K; Momose F; Morikawa Y
Biochem Biophys Res Commun; 2012 Feb; 418(1):38-43. PubMed ID: 22226969
[TBL] [Abstract][Full Text] [Related]
17. Generation and Characterization of Monoclonal Antibodies Specific to Avian Influenza H5N1 Hemagglutinin Protein.
Malik A; Mallajosyula VV; Mishra NN; Varadarajan R; Gupta SK
Monoclon Antib Immunodiagn Immunother; 2015 Dec; 34(6):436-41. PubMed ID: 26683184
[TBL] [Abstract][Full Text] [Related]
18. Development of epitope-blocking ELISA for universal detection of antibodies to human H5N1 influenza viruses.
Prabakaran M; Ho HT; Prabhu N; Velumani S; Szyporta M; He F; Chan KP; Chen LM; Matsuoka Y; Donis RO; Kwang J
PLoS One; 2009; 4(2):e4566. PubMed ID: 19238211
[TBL] [Abstract][Full Text] [Related]
19. Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies.
Kashyap AK; Steel J; Oner AF; Dillon MA; Swale RE; Wall KM; Perry KJ; Faynboym A; Ilhan M; Horowitz M; Horowitz L; Palese P; Bhatt RR; Lerner RA
Proc Natl Acad Sci U S A; 2008 Apr; 105(16):5986-91. PubMed ID: 18413603
[TBL] [Abstract][Full Text] [Related]
20. [Generation of neutralizing recombinant human antibodies for targeting highly pathogenic avian influenza A (H5N1) virus].
Sun LN; Liu QZ; Wang M; Li C; Li Z; Hu XF; Zhu LL; Li Q; Wang SW; Shu YL; Liang MF; Li DX
Bing Du Xue Bao; 2008 May; 24(3):165-71. PubMed ID: 18683551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
